InChI=1S/C57H105NO9/c1- 3- 5- 7- 9- 11- 13- 15- 17- 18- 19- 20- 21- 22- 23- 24- 25- 26- 27- 29- 31- 33- 35- 40- 44- 52(61) 58- 49(53(62) 50(60) 43- 39- 34- 32- 30- 28- 16- 14- 12- 10- 8- 6- 4- 2) 47- 66- 57- 55(64) 54(63) 56(51(45- 59) 67- 57) 65- 46- 48- 41- 37- 36- 38- 42- 48/h36- 38,41- 42,49- 51,53- 57,59- 60,62- 64H,3- 35,39- 40,43- 47H2,1- 2H3,(H,58,61) /t49- ,50+,51+,53- ,54+,55+,56- ,57- /m0/s1 |
XDALVMZANJGPPV-VSVWWTSQSA-N |
O([C@@H] 1[C@@H] ([C@H] ([C@H] ([C@H] (O1) CO) OCC=2C=CC=CC2) O) O) C[C@@H] ([C@@H] ([C@@H] (CCCCCCCCCCCCCC) O) O) NC(CCCCCCCCCCCCCCCCCCCCCCCCC) =O |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via N-acylphytosphingosine )
|
|
N- {(2S,3S,4R)- 1- [(4- O- benzyl- α- D- galactopyranosyl)oxy]- 3,4- dihydroxyoctadecan- 2- yl}hexacosanamide
|
(2S,3S,4R)- 1- (4- O- benzyl- α- D- galactopyranosyloxy)- 2- hexacosanoylaminooctadecane- 3,4- diol
|
ChEBI
|
N- [(1S,2S,3R)- 2,3- dihydroxy- 1- ({[4- O- (phenylmethyl)- α- D- galactopyranosyl]oxy}methyl)heptadecyl]hexacosanamide
|
ChEBI
|
N- [(1S,2S,3R)- 2,3- dihydroxy- 1- [[[4- O- (phenylmethyl)- α- D- galactopyranosyl]oxy]methyl]heptadecyl]hexacosanamide
|
ChEBI
|
N- [(2S,3S,4R)- 1- (4- O- benzyl- α- D- galactopyranosyloxy)- 3,4- dihydroxyoctadecan- 2- yl]hexacosanamide
|
IUPAC
|
N- [(2S,3S,4R)- 1- (4- O- benzyl- α- D- galactosyloxy)- 3,4- dihydroxyoctadecan- 2- yl]hexacosanamide
|
ChEBI
|
N- {(2S,3S,4R)- 1- [(4- O- benzyl- alpha- D- galactopyranosyl)oxy]- 3,4- dihydroxyoctadecan- 2- yl}hexacosanamide
|
PDBeChem
|